Andre Limnander

Company: Regeneron

Job title: Associate Director, Immunology & Inflammation

Seminars:

A Therapeutic Strategy to Target All Sources of IgE & Eliminate the Allergic Immune Response 9:00 am

Immunoglobulin E (IgE) is a key driver of type 1 hypersensitivity reactions and allergic disorders, which are globally increasing in number and severity Although eliminating pathogenic IgE may be a powerful way to treat allergy, no therapeutic strategy reported to date can fully ablate IgE production We describe here a therapeutic approach to durably eliminate…Read more

day: Day Two